Big Boost With 3rd Vaccination: Antibody Response Against SARS-CoV-2 in Cancer Patients With B-cell

KREMS, Austria - March 2, 2023 - PRLog -- For those affected by B-cell cancer, a third SARS-CoV-2 vaccination is of particular importance. The 3rd vaccination often results in detectable antibody production even in those patients in whom the second vaccination has no effect and is therefore necessary for basic immunization. This recent study of the Karl Landsteiner University of Health Science has been published in the scientific journal "Cancers" and highlights that antibody levels increase quite generally significantly in almost all affected individuals after the 3rd vaccination. Overall, the work provides important insights for future vaccination strategies in a particularly vulnerable population – individuals suffering from cancer of cells that are important for the immune system.

Scientific Contact
Dr. Josef Singer
Department of Internal Medicine 2
University Hospital Krems
Karl Landsteiner University of Health Sciences
Mitterweg 10
3500 Krems / Austria
T +43 2732 9004 12355
E josef.singer@krems.lknoe.at

Karl Landsteiner University of Health Sciences
Eva-Maria Gruber
Communications, PR & Marketing
Dr.-Karl-Dorrek-Straße 30
3500 Krems / Austria
T +43 2732 72090 231
M +43 664 5056211
E evamaria.gruber@kl.ac.at
W (mailto:evamaria.gruber@kl.ac.at) http://www.kl.ac.at/

Copy Editing & Distribution
PR&D – Public Relations for Research & Education
Dr. Barbara Bauder
Kollersteig 68
3400 Klosterneuburg / Austria
M +43 664 1576 350
E bauder@prd.at
W http://www.prd.at/